# Study Evaluating Single Doses of PPM-204 on the Electrical Pathways of the Heart

> **NCT00447629** · PHASE1 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer**

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** PPM-204

## Key facts

- **NCT ID:** NCT00447629
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** — (—)
- **Last updated:** 2007-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00447629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00447629, "Study Evaluating Single Doses of PPM-204 on the Electrical Pathways of the Heart". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00447629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*